BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 3513779)

  • 21. Glomerular hemodynamics of the clipped kidney: effects of captopril and diltiazem.
    Frei U; Schindler R; Matthies C; Koch KM
    J Pharmacol Exp Ther; 1992 Dec; 263(3):938-42. PubMed ID: 1469650
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cardiovascular and antihypertensive activities of the novel non-sulfhydryl converting enzyme inhibitor 2-[N-[(S)-1-ethoxycarbonyl-3-phenylpropyl]-L-alanyl]-(1S,3S,5S)-2- azabicyclo[3.3.0]octane-3-carboxylic acid (Hoe 498).
    Schölkens BA; Becker RH; Kaiser J
    Arzneimittelforschung; 1984; 34(10B):1417-25. PubMed ID: 6097268
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of angiotensin I-converting enzyme with S 9490: biochemical effects, interspecies differences, and role of sodium diet in hemodynamic effects.
    Laubie M; Schiavi P; Vincent M; Schmitt H
    J Cardiovasc Pharmacol; 1984; 6(6):1076-82. PubMed ID: 6084763
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acute effects of the oral administration of midodrine, an alpha-adrenergic agonist, on renal hemodynamics and renal function in cirrhotic patients with ascites.
    Angeli P; Volpin R; Piovan D; Bortoluzzi A; Craighero R; Bottaro S; Finucci GF; Casiglia E; Sticca A; De Toni R; Pavan L; Gatta A
    Hepatology; 1998 Oct; 28(4):937-43. PubMed ID: 9755229
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antihypertensive activity of captopril (SQ 14,225), an orally active inhibitor of angiotensin converting enzyme in conscious two-kidney perinephritic hypertensive dogs.
    Vollmer RR; Boccagno JA; Steinbacher TE; Horovitz ZP; Murthy VS
    J Pharmacol Exp Ther; 1981 Feb; 216(2):225-31. PubMed ID: 6257882
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Renal response to pentobarbital anesthesia in rats: effect of interrupting the renin-angiotensin system.
    Walker LA; Gellai M; Valtin H
    J Pharmacol Exp Ther; 1986 Mar; 236(3):721-8. PubMed ID: 3512818
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Renal hemodynamics and renal kinins after angiotensin-converting enzyme inhibition.
    Clappison BH; Anderson WP; Johnston CI
    Kidney Int; 1981 Nov; 20(5):615-20. PubMed ID: 6283229
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mechanism of the blood pressure and renal hemodynamic effects of captopril.
    Hall JE; Granger JP
    Am J Cardiol; 1982 Apr; 49(6):1527-9. PubMed ID: 7041591
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of antihypertensive treatment with alacepril on insulin resistance in diabetic spontaneously hypertensive rats.
    Sato T; Nara Y; Kato Y; Yamori Y
    Metabolism; 1996 Apr; 45(4):457-62. PubMed ID: 8609831
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of carvedilol on pulse pressure and left ventricular hypertrophy in spontaneously hypertensive rats with adriamycin nephropathy.
    Jovanovic D; Jovovic D; Mihailovic-Stanojevic N; Miloradovic Z; Naumovic R; Dimitrijevic J; Maksic N; Djukanovic L
    Biomed Pharmacother; 2009 Sep; 63(8):571-6. PubMed ID: 19013753
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antihypertensive, hemodynamic and autonomic profile of a new angiotensin converting enzyme inhibitor, SCH 33844 (spirapril).
    Baum T; Watkins RW; Sybertz EJ; Ahn HS; Nelson S; Coleman W; Tedesco R; Pula KK; Rivelli M; Sabin C
    Arch Int Pharmacodyn Ther; 1987 Apr; 286(2):230-45. PubMed ID: 2884941
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Low-dose angiotensin II reduces urinary cyclic AMP excretion in spontaneously hypertensive, but not normotensive, rats: independence from hypertension and renal hemodynamic effects of angiotensin.
    Jackson EK; Herzer WA; Mi Z; Vyas SJ; Kost CK
    J Pharmacol Exp Ther; 1999 Oct; 291(1):115-23. PubMed ID: 10490894
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative cardiovascular effects of a novel angiotensin converting enzyme inhibitor altiopril calcium (MC-838) and captopril in spontaneously hypertensive rats.
    Akima M; Shiraki Y; Sakai K
    Arch Int Pharmacodyn Ther; 1988; 292():223-36. PubMed ID: 3293543
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mechanism of action of enalapril in experimental hypertension and acute left ventricular failure.
    Sweet CS; Gaul SL; Reitz PM; Blaine EH; Ribeiro LT
    J Hypertens Suppl; 1983 Oct; 1(1):53-63. PubMed ID: 6100609
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effects of S-nitrosocaptopril on renal filtration and blood pressure in rats.
    Jia L; Blantz RC
    Eur J Pharmacol; 1998 Jul; 354(1):33-41. PubMed ID: 9726628
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Renal and hormonal responses to direct renin inhibition with aliskiren in healthy humans.
    Fisher ND; Jan Danser AH; Nussberger J; Dole WP; Hollenberg NK
    Circulation; 2008 Jun; 117(25):3199-205. PubMed ID: 18559696
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Possible involvement of ATP-dependent K-channel related mechanisms in the antihypertensive and cough suppressant effects of the novel ACE inhibitor (2S, 3aS, 7aS)-1-(N2-nicotinoyl-L-lysyl-gamma-D-glutamyl)octahydro-1H- indole-2-carboxylic acid.
    Nagata S; Takeyama K; Hosoki K; Karasawa T
    Arzneimittelforschung; 1997 Jun; 47(6):726-30. PubMed ID: 9239450
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hypotensive and hemodynamic effects of the new non-sulfhydryl angiotensin converting enzyme inhibitor N-[8-amino-1(S)-carboxyoctyl]-L-alanyl-L-proline.
    Shirota M; Iijima M; Ushijima T; Kajiwara Y; Kitabatake K
    Arzneimittelforschung; 1990 Dec; 40(12):1303-9. PubMed ID: 2095126
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of angiotensin-converting enzyme inhibition on altered renal hemodynamics induced by low protein diet in the rat.
    Fernández-Repollet E; Tapia E; Martínez-Maldonado M
    J Clin Invest; 1987 Oct; 80(4):1045-9. PubMed ID: 3308957
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hydroxypropyl-β-cyclodextrin impacts renal and systemic hemodynamics in the anesthetized dog.
    Rosseels ML; Delaunois AG; Hanon E; Guillaume PJ; Martin FD; van den Dobbelsteen DJ
    Regul Toxicol Pharmacol; 2013 Dec; 67(3):351-9. PubMed ID: 23978386
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.